SMI
11.624,02
PKT
+23,12
PKT
+0,20
%
Werbung
Analysen zu SMI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 14.11.22 | Roche Outperform | Bernstein Research | |
| 14.11.22 | Richemont Conviction Buy List | Goldman Sachs Group Inc. | |
| 14.11.22 | Richemont Outperform | RBC Capital Markets | |
| 11.11.22 | Richemont Overweight | JP Morgan Chase & Co. | |
| 11.11.22 | Richemont Buy | UBS AG | |
| 11.11.22 | Richemont Overweight | Barclays Capital | |
| 11.11.22 | Richemont Conviction Buy List | Goldman Sachs Group Inc. | |
| 11.11.22 | Richemont Buy | Jefferies & Company Inc. | |
| 11.11.22 | Richemont Overweight | JP Morgan Chase & Co. | |
| 11.11.22 | Richemont Market-Perform | Bernstein Research | |
| 11.11.22 | Richemont Outperform | RBC Capital Markets | |
| 10.11.22 | Zurich Insurance Overweight | JP Morgan Chase & Co. | |
| 10.11.22 | Zurich Insurance Overweight | Barclays Capital | |
| 10.11.22 | Zurich Insurance Buy | UBS AG | |
| 10.11.22 | Zurich Insurance Neutral | Goldman Sachs Group Inc. | |
| 10.11.22 | Zurich Insurance Overweight | JP Morgan Chase & Co. | |
| 10.11.22 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 09.11.22 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 09.11.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 09.11.22 | Swiss Re Hold | Jefferies & Company Inc. | |
| 08.11.22 | Richemont Neutral | Credit Suisse Group | |
| 04.11.22 | Swiss Re Underweight | Morgan Stanley | |
| 02.11.22 | Nestlé Underperform | Jefferies & Company Inc. | |
| 01.11.22 | Roche Hold | Deutsche Bank AG | |
| 31.10.22 | Swiss Re Sell | UBS AG | |
| 31.10.22 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 31.10.22 | ABB (Asea Brown Boveri) Buy | Goldman Sachs Group Inc. | |
| 28.10.22 | Swiss Re Sector Perform | RBC Capital Markets | |
| 28.10.22 | Swiss Re Hold | Jefferies & Company Inc. | |
| 28.10.22 | UBS Neutral | JP Morgan Chase & Co. | |
| 27.10.22 | UBS Outperform | Credit Suisse Group | |
| 27.10.22 | UBS Hold | Jefferies & Company Inc. | |
| 27.10.22 | UBS Sell | Goldman Sachs Group Inc. | |
| 27.10.22 | UBS Neutral | JP Morgan Chase & Co. | |
| 27.10.22 | Novartis Sell | Deutsche Bank AG | |
| 27.10.22 | Holcim Hold | Deutsche Bank AG | |
| 26.10.22 | Novartis Market-Perform | Bernstein Research | |
| 26.10.22 | UBS Buy | Goldman Sachs Group Inc. | |
| 26.10.22 | Novartis Underperform | Credit Suisse Group | |
| 26.10.22 | Novartis Underweight | JP Morgan Chase & Co. |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.